Kentucky Health Wire: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Kentucky Health Wire.

Press releases published on October 13, 2026

8 hours ago

Repligen to Report Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

8 hours ago

Palvella Therapeutics to Participate in the Chardan 10th Annual Healthcare Conference

Indeterminate GlobeNewswire

8 hours ago

Fan-Favorite and Limited-Edition Spinach® Green Apple-Flavored Products are Returning for the Fall Season

Indeterminate GlobeNewswire

8 hours ago

nCAP Medical, Inc. Announces Distribution Agreement with Lovell Government Services, Inc. to Provide NeuroCuple® to Federal Healthcare Systems

Indeterminate GlobeNewswire

8 hours ago

Mammogen Appoints Diagnostics Industry Leader, Dr. Robert S. Epstein, to Board of Directors

Indeterminate GlobeNewswire

8 hours ago

Prelude Announces Clinical Trial Collaboration and Supply Agreement with Lilly to Evaluate KAT6A Selective Degrader PRT13722 in Combination with Verzenio® and Inluriyo® in Patients with HR+/HER2- Breast Cancer

Indeterminate GlobeNewswire

8 hours ago

VERAXA Biotech Presents in vivo Proof-of-Concept Data for BiTAC®-ADC Technology at World ADC Congress

Indeterminate GlobeNewswire

8 hours ago

5 Questions People Ask When Every Weight Loss Approach Has Failed

Indeterminate GlobeNewswire

8 hours ago

维泰瑞隆NAMPT激活剂SIR4156的II期FORGE-LM肥胖症试验完成约50%患者入组

Indeterminate GlobeNewswire

8 hours ago

維泰瑞隆NAMPT啟動劑SIR4156的II期FORGE-LM肥胖症試驗完成約50%患者入組

Indeterminate GlobeNewswire

8 hours ago

Opus Genetics to Present at the Chardan Annual Healthcare Conference

Indeterminate GlobeNewswire

8 hours ago

Sironax Advances Enrollment in Phase 2 FORGE-LM Obesity Trial of NAMPT Activator SIR4156

Indeterminate GlobeNewswire

8 hours ago

ZoomRx Launches Marketing Asset Testing (MAT) on Sagan Agents, Bringing Continuous, Channel-Specific Asset Testing to Pharma Brand Teams

Indeterminate GlobeNewswire

8 hours ago

Aclarion to Present at the 20th Annual LD Micro Main Event

Indeterminate GlobeNewswire

8 hours ago

iBio Highlights Data from a Non-human Primate Study Supporting IBIO-610’s Potential to Preserve Muscle in Combination with GLP-1 Therapy

Indeterminate GlobeNewswire

8 hours ago

Tilray Medical Strengthens Global Medical Cannabis Supply Chain with Approval to Bring Critical EU-GMP Quality Testing In-House, Accelerating Product Release Across Regulated Global Markets

Indeterminate GlobeNewswire

8 hours ago

Triveni Bio Doses First Patient in Global Phase 2 Proof-of-Concept Study of TRIV-573 in Atopic Dermatitis and Provides I&I Pipeline Update

Indeterminate GlobeNewswire

8 hours ago

Visara Expands Ophthalmology Pipeline with Exclusive License for Investigational Nerve Growth Factor Therapy for Neurotrophic Keratitis

Indeterminate GlobeNewswire

8 hours ago

Beam Therapeutics to Present Initial Data from Phase 1/2 Trial of BEAM-301 in Glycogen Storage Disease Type Ia (GSDIa) at the ESGCT 33rd Annual Congress

Indeterminate GlobeNewswire

8 hours ago

Ever After Foods and Roslin Technologies Achieve Major Leap in Cultivated Meat Productivity

Indeterminate GlobeNewswire